Termeer Institute is ranked among medical research organizations in Marblehead, MA, with an America's Best Score of 65 out of 100, based on its 2025 Form 990.
The Termeer Institute is a catalyst for innovation that brings life-changing treatments to patients worldwide. We support and empower brilliant life science leaders to advance groundbreaking, patient-centered solutions.
Main program · fiscal year 2025
To date, over 100 leaders from nine countries and six states have benefitted from the Termeer Institute's growing leadership programs. We have also expanded our network to include termeer scholars, academic and non-profit leaders seeking to scale and disseminate their knowledge to impact patients. In 2025, we added nine new scholars to our network for a total of 14 termeer scholars across the us a… Read more
To date, over 100 leaders from nine countries and six states have benefitted from the Termeer Institute's growing leadership programs. We have also expanded our network to include termeer scholars, academic and non-profit leaders seeking to scale and disseminate their knowledge to impact patients. In 2025, we added nine new scholars to our network for a total of 14 termeer scholars across the us and africa. In 2025, we updated the scholars program to a cohort model to focus on leadership and research translation skill development, in reponse to feedback from prior year scholars. In 2025, the Termeer Institute team continued to build its values-based leadership model- delivering 25 learning sessions, awarding 20 micro grants for professional leadership development, providing 150 1:1 coaching hours with consultants and executive coaches, creating 200+ mentoring and advising relationships within the termeer network, providing 100 hours of values-driven leadership programming, and organizing over 15 in-person networking opportunities to create connections. The Termeer Institute is committed to ensuring the inclusiveness of its network, particularly in recognition of the underrepresentation of women, people with disabilities, LGBTQIA+ and Black, brown and indigenous people of color at the executive level within the biopharmaceutical industry.
$1,481,766 spent
Where each dollar went · fiscal year 2025
Of every dollar it spent, 65¢ went to programs, 17¢ to management and 18¢ to fundraising.
Programs $1,481,766
Management $392,264
Fundraising $402,711
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
65%
Meets
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$2,105,285Fiscal year 2025
Expenses$2,276,741Fiscal year 2025
Total assets$1,840,279Fiscal year 2025
Total liabilities$194,614Fiscal year 2025
Fiscal year ending December2025
Revenue$2,105,285
Expenses$2,276,741
Net income−$171,456
Net assets$1,645,665
Notable sources of revenue
Percent of total revenue
Contributions
$2,060,221
97.9%
Program services
$0
0.0%
Investment income
$45,064
2.1%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,840,279
Total liabilities
$194,614
Net assets
$1,645,665
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$3,507,717
Expenses$2,378,434
Net income$1,129,283
Net assets$1,817,121
Notable sources of revenue
Percent of total revenue
Contributions
$3,448,014
98.3%
Program services
$0
0.0%
Investment income
$59,703
1.7%
Other (net)
$0
0.0%
Assets / debt
Total assets
$2,120,553
Total liabilities
$303,432
Net assets
$1,817,121
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$521,229
Expenses$1,878,601
Net income−$1,357,372
Net assets$687,838
Notable sources of revenue
Percent of total revenue
Contributions
$924,333
177.3%
Program services
$0
0.0%
Investment income
$45,863
8.8%
Other (net)
−$448,967
−86.1%
Assets / debt
Total assets
$1,118,396
Total liabilities
$430,558
Net assets
$687,838
Compensation
Officers and key employees
$318,132
Share of expenses
16.9%
Fiscal year ending December2022
Revenue$1,212,552
Expenses$1,031,166
Net income$181,386
Net assets$1,714,652
Notable sources of revenue
Percent of total revenue
Contributions
$1,195,832
98.6%
Program services
$0
0.0%
Investment income
$16,720
1.4%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,796,459
Total liabilities
$81,807
Net assets
$1,714,652
Compensation
Officers and key employees
$288,403
Share of expenses
28.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?